Table 1

Subject demographics

ParameterSequence 1 (QAM/QPM) (n=6)Sequence 2 (QPM/QAM) (n=6)All (n=12)
Age, gender, race and ethnicity
Age (in years)
 Mean71.5 (±9.0)65.0 (±8.0)68.3 (±8.8)
 Median766869.5
 Min, max59, 7950, 7150, 79
Age, n (%)
 50–591 (16.7)1 (16.7)2 (16.7)
 60–691 (16.7)3 (50.0)4 (33.3)
 >694 (66.7)2 (33.3)6 (50.0)
Gender, n (%)
 Male4 (66.7)4 (66.7)8 (66.7)
 Female2 (33.3)2 (33.3)4 (33.3)
Race, n (%)
 White4 (66.6)6 (100.0)10 (83.3)
 Asian2 (33.3)0 (0.0)2 (16.7)
Ethnicity, n (%)
 Not Hispanic6 (100.0)6 (100.0)12 (100.0)
Diagnosis
Ocular conditions n (%)
 Ocular HTN1 (16.7)5 (83.3)6 (50.0)
 OAG5 (83.3)1 (16.7)6 (50.0)
Previous IOP-lowering drugs, n (%)
 TCAI4 (66.7)2 (33.3)6 (50.0)
 PGA4 (66.7)2 (33.3)6 (50.0)
β-Blocker2 (33.3)1 (16.7)3 (25.0)
 Other3 (50.0)2 (33.3)5 (41.7)
 None0 (0.0)1 (16.7)1 (8.3)
  • HTN, hypertension; IOP, intraocular pressure; OAG, open-angle glaucoma; PGA, prostaglandin analogue; QAM, once daily morning; QPM, once daily evening; TCAI, topical carbonic anhydrase inhibitors.